Masaaki Terashima

1.7k total citations
72 papers, 1.4k citations indexed

About

Masaaki Terashima is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Masaaki Terashima has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Masaaki Terashima's work include Lung Cancer Treatments and Mutations (10 papers), Protein Hydrolysis and Bioactive Peptides (10 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Masaaki Terashima is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Protein Hydrolysis and Bioactive Peptides (10 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Masaaki Terashima collaborates with scholars based in Japan, United States and Germany. Masaaki Terashima's co-authors include Shigeo Katoh, Hiroyuki Yoshida, Eizô Sada, Kazuhiko Nakagawa, Isamu Okamoto, Taroh Satoh, Masahiro Fukuoka, Yoko Ejiri, Minoru Takada and Takafumi Okabe and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Masaaki Terashima

72 papers receiving 1.4k citations

Peers

Countries citing papers authored by Masaaki Terashima

Since Specialization

Citations

This map shows the geographic impact of Masaaki Terashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Terashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Terashima more than expected).

Fields of papers citing papers by Masaaki Terashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Terashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Terashima. The network helps show where Masaaki Terashima may publish in the future.

Co-authorship network of co-authors of Masaaki Terashima

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Terashima. A scholar is included among the top collaborators of Masaaki Terashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Terashima. Masaaki Terashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer 2024 ·Cancers ·(unknown), Takayo Ota, (unknown), Yuki Takeyasu, Satoaki Nakamura, Masaaki Terashima, Hiroshige Yoshioka, Masahiro Fukuoka, Takayasu Kurata	1
2	Antioxidant activities of a peptide derived from chicken dark meat 2016 ·Journal of Food Science and Technology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kumiko Nagai, Yuki Murakami, (unknown), (unknown), Masaaki Terashima	16
3	Comprehensive Evaluation of the Antioxidant Activity of Miso by the Myoglobin Method 2014 ·Food Science and Technology Research ·(unknown), Yukio Ando, (unknown), (unknown), (unknown), Masaaki Terashima	4
4	Tolerability of Nintedanib (BIBF 1120) in Combination with Docetaxel: A Phase 1 Study in Japanese Patients with Previously Treated Non–Small-Cell Lung Cancer 2014 ·Journal of Thoracic Oncology ·Isamu Okamoto, Masaki Miyazaki, Masayuki Takeda, Masaaki Terashima, Koichi Azuma, Hidetoshi Hayashi, Hiroyasu Kaneda, Takayasu Kurata, Junji Tsurutani, Takashi Seto, Fumihiko Hirai, (unknown), Akiko Sarashina, (unknown), R. Kaiser, Kazuhiko Nakagawa	30
5	Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung 2013 ·Cancer Chemotherapy and Pharmacology ·(unknown), Isamu Okamoto, Masayuki Takeda, Haruko Daga, Tateaki Naito, Masaki Miyazaki, (unknown), Hidetoshi Hayashi, Kaoru Tanaka, Masaaki Terashima, Koichi Azuma, Haruyasu Murakami, Koji Takeda, Nobuyuki Yamamoto, Kazuhiko Nakagawa	7
6	A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer 2012 ·Investigational New Drugs ·Yoshikazu Hasegawa, Isamu Okamoto, Ken Takezawa, (unknown), Junji Tsurutani, Kimio Yonesaka, (unknown), Asuka Tsuya, Masaaki Terashima, (unknown), Koichi Azuma, Takayasu Kurata, (unknown), Masahiro Fukuoka, Yasumasa Nishimura, Kazuhiko Nakagawa	2
7	Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B 2011 ·Breast Cancer ·Hidetoshi Hayashi, Junji Tsurutani, (unknown), Norikazu Masuda, Wataru Okamoto, Ryotaro Morinaga, Masaaki Terashima, Masaki Miyazaki, Isamu Okamoto, (unknown), (unknown), Yukihiko Tokunaga, (unknown), Junichi Sakamoto, Takahiro Nakayama, Kazuhiko Nakagawa	14
8	Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors 2010 ·Molecular Cancer Therapeutics ·Isamu Okamoto, Hiroyasu Kaneda, Taroh Satoh, Wataru Okamoto, Masaki Miyazaki, Ryotaro Morinaga, Shinya Ueda, Masaaki Terashima, Asuka Tsuya, Akiko Sarashina, (unknown), Tokuzo Arao, Kazuto Nishio, R. Kaiser, Kazuhiko Nakagawa	79
9	Tandem multimer expression of angiotensin I‐converting enzyme inhibitory peptide in Escherichia coli 2009 ·Biotechnology Journal ·(unknown), Yoichi Kumada, Masaaki Terashima, Tomohisa Katsuda, Shigeo Katoh	12
10	Effects of Reaction Condition on Conversion of Fish Meat into Organic Acids and Amino Acids by Sub-critical Water Hydrolysis 2001 ·Journal of the Japan Society of Waste Management Experts ·Hiroyuki Yoshida, Masaaki Terashima, Yohei Takahashi	6
11	Utilization of an Alternative Carbon Source for Efficient Production of Human α₁‐Antitrypsin by Genetically Engineered Rice Cell Culture 2001 ·Biotechnology Progress ·Masaaki Terashima, Yoko Ejiri, (unknown), Hiroyuki Yoshida	20
12	Effects of sugar concentration on recombinant human α1-antitrypsin production by genetically engineered rice cell 2000 ·Biochemical Engineering Journal ·Masaaki Terashima, Yoko Ejiri, (unknown), Hiroyuki Yoshida	17
13	Utilization of antipeptide antibodies as affinity ligands in immunoaffinity purification 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·Shigeo Katoh, Masaaki Terashima, Naofumi Shiomi	5
14	Modification of Alpha‐Amylase Functions by Protein Engineering 1996 ·Annals of the New York Academy of Sciences ·Masaaki Terashima, Shigeo Katoh	14
15	The Roles of the N-linked Carbohydrate Chain of Rice alpha-Amylase in Thermostability and Enzyme Kinetics 1994 ·European Journal of Biochemistry ·Masaaki Terashima, Atsushi Kubo, (unknown), (unknown), Shigeo Katoh	29
16	A Measurement of Complement Activity Using Immunoliposome 1990 ·Annals of the New York Academy of Sciences ·(unknown), Hideki Yamaji, Hideki Fukuda, Masaaki Terashima, Shigeo Katoh, Eizô Sada, Hiroshi Taniguchi	1
17	Stability and reaction characteristics of reverse‐phase evaporation vesicles (REVs) as enzyme containers 1990 ·Biotechnology and Bioengineering ·Eizô Sada, Shigeo Katoh, Masaaki Terashima, (unknown), Yasushi Miura	6
18	Carrier‐mediated transport across phospholipid composite membranes using monensin as pH‐dependent carrier 1987 ·Biotechnology and Bioengineering ·Eizô Sada, Shigeo Katoh, Masaaki Terashima, Masahito Yamamoto	7
19	Amino acid sequences of phospholipases A2 from the venom of an Australian elapid snake (king brown snake, Pseudechis australis) 1985 ·Toxicon ·Shigeru Nishida, Masaaki Terashima, Nobuo Tamiya	31
20	Diffusive and hydraulic transfer of solutes through homogeneous membranes 1982 ·Biotechnology and Bioengineering ·Eizô Sada, Shigeo Katoh, (unknown), Masaaki Terashima, Shuichi Yoshida	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact